Fresenius Kabi articles & resources on Made-in-China.com

Fenwal Receives FDA 510(K) Clearance for The Alyx System Software Version 3.1.

Nov 25, 2013

Fenwal, a Fresenius Kabi company, has received the US Food and Drug Administration (FDA) 510(k) clearance for the Alyx system software version 3.1. The new software gives the Alyx system a protocol for closed system plasma collection and ...

Tags: Fenwal Alyx System, Plasma Protocol Software

Fresenius Kabi Rolled out Its Levofloxacin in 5% Dextrose Injection in Freeflex Containers

Sep 3, 2013

Global health care company Fresenius Kabi USA has rolled out its Levofloxacin in 5% Dextrose injection in freeflex containers, designed for better infusion of solutions. Considering easy handling with improved safety and environmental ...

Tags: Fresenius Kabi, Freeflex Container

Availability of Levofloxacin IV in Freeflex Container Is Announced by Fresenius Kabi

Sep 2, 2013

Fresenius Kabi USA has announced the availability of Levofloxacin in 5% dextrose injection in freeflex containers. Freeflex is a PVC-free, plasticizer-free, non-DEHP container, which is designed for easy handling and infusing the ...

Tags: Fresenius Kabi, Freeflex Container

IPAB Cancelled The Patent for GSK's Anti-Cancer Drug Tykerb

Aug 6, 2013

The Intellectual Property Appellate Board (IPAB) in India has cancelled the patent for GlaxoSmithKline's (GSK) anti-cancer drug Tykerb in its salt form over failure in demonstrating significant improvement in the efficacy. Fresenius ...

Tags: Anti-Cancer Drug

Fresenius Kabi USA Has Issued Voluntary Nationwide Recall

Jul 2, 2013

Fresenius Kabi USA has issued voluntary nationwide recall of four lots of benztropine mesylate injection, USP 2mg/2mL (1mg/mL), in 2mL single dose vials. Being conducted at the user level, the recall is due to the potential presence of ...

Tags: Fresenius Kabi, Benztropine Mesylate Injection

Fresenius Kabi USA Commenced a Voluntary Recall of One Lot of Magnesium Sulfate Injection

May 27, 2013

Fresenius Kabi USA has commenced a voluntary recall of one lot of Magnesium Sulfate Injection, USP, as part of its precautionary measure. After a regular company inspection of retained product samples, the recall was announced due to the ...

Tags: Fresenius Kabi, recalled product

FDA Approved InnoPharma's Abbreviated New Drug Application for Acetylcysteine Injection

Jan 10, 2013

The US Food and Drug Administration (FDA) has approved InnoPharma's abbreviated new drug application (ANDA) for acetylcysteine injection. The acetylcysteine injection, which is a generic equivalent of Cumberland Pharmaceuticals' Acetadote ...

Tags: FDA, acetylcysteine injection, Pharmaceuticals, acetaminophen

Fenwal Will Be Bought by Fresenius for Blood and Cell Collection and Therapy.

Dec 18, 2012

Fresenius Kabi has entered into a definitive agreement to purchase Fenwal, a provider of separation technologies for blood and cell collection and therapy. Under the acquisition, both the companies are working together to bring their ...

Tags: acquisition, medical technology, medical service, expansion

Fresenius Kabi USA Has Announced The Availability of Acetylcysteine Solution, USP

Nov 29, 2012

Fresenius Kabi USA has announced the availability of Acetylcysteine Solution, USP, 20% 30ml vial for inhalation (mucolytic agent) or oral administration (acetaminophen antidote) to treat lung diseases. Acetylcysteine Solution, USP, ...

Tags: Acetylcysteine Solution, lung diseases, critical care products

APP Pharmaceuticals Has Purchased Three Products

Nov 28, 2012

APP Pharmaceuticals, a Fresenius Kabi Company, has purchased three products, Benztropine Mesylate Injection, Levetiracetam Injection and Tranexamic Acid Injection, from Nexus Pharmaceuticals. As per the agreement, APP acquires complete ...

Tags: APP Pharmaceuticals, Benztropine Mesylate Injection

Fresenius Kabi

Related Products